文献速递神经肿瘤

基于术前全脑纤维束成像可切除性指标预测弥漫性高级别胶质瘤生存结局

Prediction of Diffuse High-Grade Glioma Survival Outcomes Using Preoperative Whole-Brain Tractography-Based Resectability Metrics.
PubMed 文献 · Neurosurgery · 2025-08-07

本研究回顾性分析146例弥漫性高级别胶质瘤成人患者,其中84例有术前全脑纤维束成像数据,开发了基于纤维束成像的可切除性指标(可切除性指数RI及改良指标mRI、不可切除肿瘤体积UTV及mUTV),发现mRI和mUTV能准确预测活检与切除,且mUTV是总生存的独立预测因子,基于WBT的术后生存模型C-index显著优于传统指标。

要点

  • mRI和mUTV基于术前影像即可计算,能准确区分活检与切除。
  • mRI高于0.65者中位总生存未达到,低于0.65者为82天。
  • 基于WBT可切除性指标的生存模型C-index高于EOR和残留肿瘤体积。

核心结论

  • 基于全脑纤维束成像的可切除性指标可术前计算,并强预测高级别胶质瘤活检或切除术后的生存结局。

研究设计与样本

  • 回顾性分析连续成人活检或切除的高级别胶质瘤病例,共分析146个肿瘤,其中84个有术前全脑纤维束成像数据。

主要发现

  • mRI预测活检与切除的AUC为0.953,mUTV的AUC为0.854,截断值分别为0.75和2.5 cm³。
  • mRI高于0.65与低于0.65的肿瘤中位总生存差异显著(未达到 vs 82天,P < .0001)。
  • 仅用术前协变量的log-logistic AFT模型k折验证平均C-index为0.788,mUTV为独立预测因子(P = .008)。
  • 使用WBT可切除性指标的术后总生存模型平均C-index显著高于使用EOR和残留肿瘤体积的模型(0.927 vs 0.874,P < .001)。

关键数值与推荐

  • mRI截断值0.75用于预测活检与切除,mUTV截断值2.5 cm³用于预测活检与切除。
  • mRI截断值0.65用于区分中位总生存的显著差异。

临床怎么用

  • 术前可基于全脑纤维束成像计算mRI和mUTV,辅助判断肿瘤可切除性并预测生存,帮助手术决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Extent of resection (EOR) is a recognized predictor of survival in adults with diffuse high-grade glioma (HGG) but can only be calculated postoperatively. We developed novel whole-brain tractography (WBT)-based metrics to quantify tumor resectability and predict survival outcomes using only preoperative data. METHODS: Consecutive adults with biopsied or resected HGGs were retrospectively reviewed. Unresectable tumor volume (UTV) was the total overlapping volume of tumor with eloquent tracts and deep brain structures. Resectability index (RI) was (preoperative tumor volume [PTV]-UTV)/PTV, where PTV was preresection tumor volume. Modified metrics (mRI and mUTV) considered only the corticospinal tract and left arcuate fasciculus. Progression-free and overall survival (OS) were modeled using Cox proportional hazards and accelerated failure time (AFT) multivariable regression. RESULTS: We analyzed 146 tumors, of which 84 had preoperative WBT available. Both mRI (area under receiver operating characteristic curve = 0.953) and mUTV (area under receiver operating characteristic curve = 0.854) had robust accuracy in predicting biopsy vs resection at cutoff values of 0.75 and 2.5 cm 3 , respectively. Tumors with the mRI above and below 0.65 had the most significant difference in median OS (not reached vs 82 days, P < .0001). The best-performing AFT model of OS using only preoperative covariates was a log-logistic AFT model (k-fold validated mean C-index = 0.788), in which mUTV was an independent predictor of outcome ( P = .008). Postoperative OS models using WBT-based resectability metrics exhibited significantly higher mean C-indices compared with those using the conventional metrics, EOR and residual tumor volume (0.927 vs 0.874, P < .001). CONCLUSION: Our patient-specific WBT-based HGG resectability metrics closely approximate EOR and residual tumor volume, can be calculated on preoperative imaging, and are strong predictors of survival outcomes after HGG biopsy or resection.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Nichols NM, Seenarine N, Le CH, et al. Prediction of Diffuse High-Grade Glioma Survival Outcomes Using Preoperative Whole-Brain Tractography-Based Resectability Metrics. Neurosurgery. 2025. PMID: 40772761. doi:10.1227/neu.0000000000003668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。